-
1.发明授权Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis 有权含有用于治疗牛皮癣的纳米液的局部药物组合物公开(公告)号：US08992994B2
公开(公告)日：2015-03-31
申请号：US13880519
申请日：2011-10-18
申请人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
发明人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
CPC分类号： A61K9/107 , A61K9/0014 , A61K9/1075 , A61K31/573 , A61K31/60 , A61K47/44 , B82Y5/00 , A61K2300/00
摘要： The present invention relates to stable topical pharmaceutical compositions for the treatment of psoriasis. Disclosed are in particular nonoemulsions comprising nano size droplets of one or more anti-psoriasis agents, e.g. clobetasol and/or salicylic acid. These compositions exhibit greater permeability, and improved bioavailability. The invention also relates to processes for the preparation of such compositions.
摘要翻译： 本发明涉及用于治疗牛皮癣的稳定的局部药物组合物。 公开了特别是包含一种或多种抗牛皮癣药剂的纳米尺寸液滴的非乳液，例如。 氯倍他索和/或水杨酸。 这些组合物表现出更大的渗透性和改善的生物利用度。 本发明还涉及制备这种组合物的方法。
-
公开(公告)号：US20130295145A1
公开(公告)日：2013-11-07
申请号：US13880302
申请日：2011-10-18
申请人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
发明人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
IPC分类号： A61K9/06 , A61K31/618 , A61K31/407
CPC分类号： A61K9/06 , A61K9/0014 , A61K9/1075 , A61K31/407 , A61K31/618 , A61K47/06 , A61K47/32 , A61K47/44
摘要： The present invention relates to stable pharmaceutical compositions comprising nano size droplets of etodolac or salts thereof along with other pharmaceutically acceptable excipients. These compositions exhibit greater permeability, and improved bioavailability leading to enhanced therapeutic activity. The invention also relates to processes for the preparation of such compositions.
摘要翻译： 本发明涉及稳定的药物组合物，其包含依托托卡酸的纳米尺寸液滴或其盐与其它药学上可接受的赋形剂。 这些组合物显示出更大的渗透性，并且改善了生物利用度，导致增强的治疗活性。 本发明还涉及制备这种组合物的方法。
-
公开(公告)号：US10028972B2
公开(公告)日：2018-07-24
申请号：US13880187
申请日：2011-10-19
申请人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jinesh Suresh Pancholi , Jitendra Dasharathlal Patel , Ravindra Mittal
发明人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jinesh Suresh Pancholi , Jitendra Dasharathlal Patel , Ravindra Mittal
IPC分类号： A61K9/107 , A61K31/7056 , A61K9/00 , A61K9/06 , A61K31/192 , A61K45/06 , A61K47/32 , A61K47/44
摘要： The present invention relates to pharmaceutical compositions for treatment of acne. In particular, the present invention relates to stable pharmaceutical compositions for treatment of acne along with other pharmaceutically acceptable excipients. These compositions exhibit excellent stability, greater permeability, and enhanced therapeutic efficacy. The invention also relates to processes for the preparation of such compositions.
-
公开(公告)号：US09713590B2
公开(公告)日：2017-07-25
申请号：US14234847
申请日：2012-01-05
IPC分类号： A61K9/107 , A61K31/196 , A61K9/00
CPC分类号： A61K9/1075 , A61K9/0014 , A61K31/196
摘要： The present invention relates to a method for the treatment of pain and inflammation. In particular, the present invention relates to a method for the treatment of musculo-skeletal and connective tissue pain/inflammations. Further, the invention relates to reducing the incidence and seventy of adverse events resulting from administration of diclofenac. The method comprises administration of a topical pharmaceutical composition of diclofenac or its salts.
-
公开(公告)号：US09629785B2
公开(公告)日：2017-04-25
申请号：US13880342
申请日：2011-10-18
申请人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
发明人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
IPC分类号： A61Q9/02 , A61K8/06 , A61K8/34 , A61K8/35 , A61K8/362 , A61K8/365 , A61K8/49 , A61K8/63 , A61K8/67 , A61Q19/02 , A61K8/36
CPC分类号： A61K8/06 , A61K8/347 , A61K8/355 , A61K8/361 , A61K8/362 , A61K8/365 , A61K8/4946 , A61K8/4973 , A61K8/63 , A61K8/671 , A61K8/675 , A61K2800/20 , A61K2800/21 , A61K2800/413 , A61Q19/02 , Y10S977/773 , Y10S977/906
摘要： The present invention relates to pharmaceutical compositions comprising mono size droplets of skin whitening agents or salts thereof. In particular, the present invention relates to a stable pharmaceutical composition comprising skin whitening agents or salts thereof along with other pharmaceutically acceptable excipients which possess substantially improved skin whitening effects and also exhibits greater skin permeability. The invention also relates to processes for the preparation of such compositions.
-
6.发明申请TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING NANODROPLETS FOR THE TREATMENT PSORIASIS 有权含有NANODROPLETS用于治疗PSORIASIS的局部药物组合物公开(公告)号：US20130273172A1
公开(公告)日：2013-10-17
申请号：US13880519
申请日：2011-10-18
申请人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
发明人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
IPC分类号： A61K9/107 , A61K31/573 , A61K31/60
CPC分类号： A61K9/107 , A61K9/0014 , A61K9/1075 , A61K31/573 , A61K31/60 , A61K47/44 , B82Y5/00 , A61K2300/00
摘要： The present invention relates to stable topical pharmaceutical compositions for the treatment of psoriasis. Disclosed are in particular nonoemulsions comprising nano size droplets of one or more anti-psoriasis agents, e.g. clobetasol and/or salicylic acid. These compositions exhibit greater permeability, and improved bioavailability. The invention also relates to processes for the preparation of such compositions.
摘要翻译： 本发明涉及用于治疗牛皮癣的稳定的局部药物组合物。 公开了特别是包含一种或多种抗牛皮癣药剂的纳米尺寸液滴的非乳液，例如。 氯倍他索和/或水杨酸。 这些组合物表现出更大的渗透性和改善的生物利用度。 本发明还涉及制备这种组合物的方法。
-
公开(公告)号：US20090247765A1
公开(公告)日：2009-10-01
申请号：US12303235
申请日：2006-09-04
申请人： Kirtipalsinh Sajjansinh Solanki , Manoj Kumar Singh , Jay Shantilal Kothari , Virenda Kumar Agarwal
发明人： Kirtipalsinh Sajjansinh Solanki , Manoj Kumar Singh , Jay Shantilal Kothari , Virenda Kumar Agarwal
IPC分类号： C07D249/08
CPC分类号： C07D249/08
摘要： The present invention discloses two new related substances (6) and (7) of Anastrozole synthesis from Q. A. Salt (5) as in Scheme—1 and purification procedures to get Anastrozole (1) free from (6) and (7).
摘要翻译： 本发明公开了如方案-1中的Q.A盐（5）和得自（6）和（7）所述的阿那曲唑（1）的纯化程序的两种新的相关物质（6）和（7）。
-
8.发明申请PHARMACEUTICAL COMPOSITIONS COMPRISING NANO SIZE DROPLETS OF SKIN WHITENING AGENTS 有权包含皮肤白化剂的纳米尺寸滴剂的药物组合物公开(公告)号：US20130287825A1
公开(公告)日：2013-10-31
申请号：US13880342
申请日：2011-10-18
申请人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
发明人： Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
CPC分类号： A61K8/06 , A61K8/347 , A61K8/355 , A61K8/361 , A61K8/362 , A61K8/365 , A61K8/4946 , A61K8/4973 , A61K8/63 , A61K8/671 , A61K8/675 , A61K2800/20 , A61K2800/21 , A61K2800/413 , A61Q19/02 , Y10S977/773 , Y10S977/906
摘要： The present invention relates to pharmaceutical compositions comprising mono size droplets of skin whitening agents or salts thereof. In particular, the present invention relates to a stable pharmaceutical composition comprising skin whitening agents or salts thereof along with other pharmaceutically acceptable excipients which possess substantially improved skin whitening effects and also exhibits greater skin permeability. The invention also relates to processes for the preparation of such compositions.
摘要翻译： 本发明涉及包含皮肤增白剂或其盐的单大小滴的药物组合物。 特别地，本发明涉及稳定的药物组合物，其包含皮肤增白剂或其盐以及具有显着改善的皮肤美白效果并且还具有更高的皮肤渗透性的其它药学上可接受的赋形剂。 本发明还涉及制备这种组合物的方法。
-
9.发明授权公开(公告)号：US09636353B2
公开(公告)日：2017-05-02
申请号：US13880092
申请日：2011-10-19
申请人： Ravindra Mittal , Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
发明人： Ravindra Mittal , Sunilendu Bhushan Roy , Jay Shantilal Kothari , Shafiq Sheikh , Jitendra Dasharathlal Patel , Jinesh Suresh Pancholi
IPC分类号： A61K31/7056 , A61K31/192
CPC分类号： A61K31/7056 , A61K31/192 , A61K2300/00
摘要： The present invention relates to a method for treating, reducing or preventing acne. In particular, the present invention relates to methods for reducing the total number, incidence and severity of acne lesions on the skin which includes both inflammatory and non-inflammatory lesions. Further, the invention relates to reducing the incidence and severity of adverse events resulting from topical application of anti-acne agents resulting in improvement of skin tone. The method includes administering a novel and stable topical anti-acne pharmaceutical composition.
-
公开(公告)号：US08058302B2
公开(公告)日：2011-11-15
申请号：US12303235
申请日：2006-09-04
申请人： Kirtipalsinh Sajjansinh Solanki , Manoj Kumar Singh , Jay Shantilal Kothari , Virendra Kumar Agarwal
发明人： Kirtipalsinh Sajjansinh Solanki , Manoj Kumar Singh , Jay Shantilal Kothari , Virendra Kumar Agarwal
IPC分类号： A61K31/41 , C07D249/00
CPC分类号： C07D249/08
摘要： The present invention discloses two new related substances (6) and (7) of Anastrozole synthesis from Q.A. Salt (5) as in Scheme—1 and purification procedures to get Anastrozole (1) free from (6) and (7).
摘要翻译： 本发明公开了两种新的相关物质（6）和（7）。 盐（5）如方案-1和纯化程序得到不含（6）和（7）的阿那曲唑（1）。
-
-
-
-
-
-
-
-
-
搜索结果
19 条记录 (耗时 0.014 秒)
